QDEL (QuidelOrtho) Cyclically Adjusted Revenue per Share: $35.50 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

QDEL QuidelOrtho Corp QDEL
43 GF Score
Price $17.04
GF Value $37.36
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is QuidelOrtho Cyclically Adjusted Revenue per Share?

QuidelOrtho QDEL -1.90% 43 Cyclically Adjusted Revenue per Share is $35.50 as of Mar. 2026. GuruFocus rates QDEL with a GF Score™ of 43/100 and a GF Value™ of $37.36 (Possible Value Trap). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

QuidelOrtho's adjusted revenue per share for the three months ended in Mar. 2026 was $9.088. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $35.50 for the trailing ten years ended in Mar. 2026.

During the past 12 months, QuidelOrtho's average Cyclically Adjusted Revenue Growth Rate was 13.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 16.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 25.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 24.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of QuidelOrtho was 42.90% per year. The lowest was -2.20% per year. And the median was 6.00% per year.

As of today (2026-07-20), QuidelOrtho's current stock price is $17.04. QuidelOrtho's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $35.50. QuidelOrtho's Cyclically Adjusted PS Ratio of today is 0.48.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of QuidelOrtho was 35.44. The lowest was 0.29. And the median was 5.24.


QuidelOrtho  (NAS:QDEL) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

QuidelOrtho's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=17.04/35.50
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of QuidelOrtho was 35.44. The lowest was 0.29. And the median was 5.24.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


QuidelOrtho Cyclically Adjusted Revenue per Share Related Terms


QuidelOrtho Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for QuidelOrtho's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QuidelOrtho Cyclically Adjusted Revenue per Share Chart

QuidelOrtho Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.92 21.35 25.89 30.08 34.15

QuidelOrtho Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.28 32.32 33.38 34.15 35.50

QDEL vs AVR, INMD, CNMD: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, QuidelOrtho's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QuidelOrtho Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QuidelOrtho's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where QuidelOrtho's Cyclically Adjusted PS Ratio falls into.


QDEL
43GF Score
QuidelOrtho Corp QDEL
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

QuidelOrtho Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, QuidelOrtho's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=9.088/330.2130*330.2130
=9.088

Current CPI (Mar. 2026) = 330.2130.

QuidelOrtho Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 1.203 241.018 1.648
201609 1.510 241.428 2.065
201612 1.605 241.432 2.195
201703 2.168 243.801 2.936
201706 1.142 244.955 1.539
201709 1.501 246.819 2.008
201712 3.347 246.524 4.483
201803 4.032 249.554 5.335
201806 2.720 251.989 3.564
201809 2.737 252.439 3.580
201812 3.097 251.233 4.071
201903 3.449 254.202 4.480
201906 2.613 256.143 3.369
201909 2.928 256.759 3.766
201912 3.515 256.974 4.517
202003 4.024 258.115 5.148
202006 4.612 257.797 5.908
202009 10.920 260.280 13.854
202012 18.552 260.474 23.519
202103 8.622 264.877 10.749
202106 4.165 271.696 5.062
202109 11.995 274.310 14.440
202112 14.442 278.802 17.105
202203 23.639 287.504 27.151
202206 11.595 296.311 12.922
202209 11.612 296.808 12.919
202212 12.933 296.797 14.389
202303 12.610 301.836 13.796
202306 9.957 305.109 10.776
202309 11.121 307.789 11.931
202312 11.117 306.746 11.967
202403 10.628 312.332 11.236
202406 9.493 314.175 9.978
202409 10.804 315.301 11.315
202412 10.486 315.605 10.971
202503 10.264 319.799 10.598
202506 9.068 322.561 9.283
202509 10.293 324.800 10.465
202512 10.626 324.054 10.828
202603 9.088 330.213 9.088

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $35.50 mean?
QuidelOrtho (QDEL) has a Cyclically Adjusted Revenue per Share of $35.50 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on QuidelOrtho and its competitors.
Is QuidelOrtho's Cyclically Adjusted Revenue per Share too high?
QuidelOrtho's current Cyclically Adjusted Revenue per Share is $35.50. Overall, QuidelOrtho has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does QuidelOrtho's Cyclically Adjusted Revenue per Share compare to AVR and INMD?
QuidelOrtho's Cyclically Adjusted Revenue per Share of $35.50 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on QuidelOrtho and its competitors. QuidelOrtho's current Cyclically Adjusted Revenue per Share is $35.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QuidelOrtho stock overvalued right now?
Based on GuruFocus' analysis, QuidelOrtho (QDEL) is currently considered Possible Value Trap. The stock's GF Value™ is $37.36, compared to a current price of $17.04 — trading 54.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $35.50. QuidelOrtho's overall GF Score™ is 43/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For QuidelOrtho (QDEL), the current Cyclically Adjusted Revenue per Share is $35.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is QuidelOrtho (QDEL) Overvalued in 2026?

Based on GuruFocus' analysis, QuidelOrtho stock appears to be undervalued. The current stock price of $17.04 is trading 54.4% below its estimated GF Value™ of $37.36. GuruFocus considers QuidelOrtho to be Possible Value Trap.

Key valuation signals for QDEL:

  • Cyclically Adjusted Revenue per Share: $35.50
  • GF Value™: $37.36 vs. price of $17.04 (54.4% below fair value)
  • GF Score™: 43/100 with 8 warning signs

No single metric tells the full story. See the QDEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


QuidelOrtho Business Description

Other Exchanges 0A55:UKQL1A:Germany
Address 9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
43GF Score

Get the complete analysis for QDEL

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.04
Price
$37.36
GF Value